House of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home. MAJ Meghan Raleigh, MD 17 MAR 2014

Size: px
Start display at page:

Download "House of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home. MAJ Meghan Raleigh, MD 17 MAR 2014"

Transcription

1 House of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home MAJ Meghan Raleigh, MD 17 MAR 2014

2 Make this house your own!

3 Objectives Review key components in PCMH Identify barriers to comprehensive pain management Identify Universal Precautions approach to chronic pain Increase comfort level with delivering multidisciplinary care to chronic pain patients utilizing the PCMH model Recognize available practice tools / resources

4 PCMH Key Components Access to Care Care Team and Staffing Chronic Disease Care Electronic Medical Records Group Visits Patient-Centered Care Patient Self-Management Practice Efficiency Quality and Safety

5 Intro Pain is the primary reason Americans seek health care Over 116 million Americans suffer chronic pain Opioids widely prescribed for chronic pain, even in high-doses not shown to affect pain (Gomes 2011) Daily dose of opioid is strongly associated with opioid-related mortality (Gomes 2011) Institute of Medicine report concluded that effective treatment of chronic pain demands a cultural shift from physicians & patients

6 Why are these patients challenging? We expect them to be: Time-consuming Deceitful Demanding Exploitive Difficult Non-adherent Manipulative Abusive Impossible to Drug-seeking please These beliefs are formed as early as medical school (Evans 2011)

7 Barriers to Comprehensive Pain Management Insufficient time Inadequate pain assessment No objective measures of pain Concern of drug-seeking behavior Concern of addiction Concern of prescription abuse/misuse Lack of pain management training News media coverage about opioid overdoses Fear of regulatory scrutiny or investigation

8 Universal Precautions Approach First introduced by Gourlay & colleagues in step approach to all patients with chronic pain Allows for unbiased applications of treatment plans to chronic pain patients Includes regular monitoring Reduces under-treatment of pain when opioids are necessary Zakaroff 2014; Gourlay 2005

9 Universal Precautions Approach Diagnose with appropriate differential Psychological Assessment Including Risk of Addictive Disorders Informed Consent Treatment Agreement Pre- and Post- Intervention Assessment of Pain Level and Function Appropriate trial of Opioid Therapy +/- Adjunctive Medication Zakaroff 2014; Gourlay 2005

10 Universal Precautions Approach C td Reassessment of pain score and level of function Regularly assess the four A s of pain medicine (Passok 2000) Analgesia Activity Adverse effects Aberrant Behavior Periodically review pain diagnosis and comorbid conditions, including addictive disorders

11 So how do we implement this in the PCMH? Tenets of PCMH: Teamwork Coordination, integration of care Working to the top of training scope Utilization of clinical decision support tools Patient self-management Quality Improvement

12 Standardized Approach to the Chronic Pain Patient Identify patients on opioid therapy (OT) for >90 days Establish clinic informed consent, pain contract, & individual treatment plan Establish no telephone refill policy Internal Behavioral Health Consult to address barriers to treatment plan & comorbid conditions Pharm D to address polypharmacy & make med recs Physical Therapist to assist w/functional assessment/goals N trition

13 Identifying patients Patients on opioids > 90 days 2010 VA/DoD CPG no longer distinguishes nonmalignant chronic pain and cancer-related chronic pain Identified by provider Identified by clinic (ie, calling in for refills, during pre-huddle appointment scrubs) Proactive identification Pharm-D looks up patients who have been on OT for >90 days, calls to recommend PCM appointment to set up appointment

14 Before the Visit Identify patients In huddle, pre-visit scrubs Set expectation about new clinic policy Pain contract No phone refills Via phone or Secure Messaging

15 Before the Visit Continued Collect info prior to visit Pharm D can get PDMP report Have patient fill out standardized survey for pain assessment / functional assessment / depression screen Utilize Secure Messaging to send forms & copy of pain contract Clinical Assistant can get baseline UDS this is our clinic standard of care for chronic pain Review records Inquire what patient goals for the visit are

16 The Visit Clean Slate Set the tone for a positive relationship History & Focused Physical Evaluate for contributing co-morbidities Sleep disorders Depression Anxiety PTSD Personality disorders Substance use disorder (or history)

17 The Visit Clean Slate Pain & Functional Assessment Review pre-visit forms Review Mechanism of Pain Discover what is the most important to patient Functional goals Pain reduction Improved sleep Improved family relationships/emotional well being

18 The Visit Clean Slate c td Set realistic expectations FUNCTION, not elimination of pain Make follow up appointment What is the goal of the next visit? Pain contract / informed consent/ treatment plan Can be done by clinical assistant / Pharm D Treatment plan may evolve over time

19 Pain Journal

20 Pain Contract Having standard clinic policy removes stigma of pain agreement Over 60% of chronic patients comply with their pain contracts (Hariharan 2007) Include informed consent! Add section with patient-specific treatment plan Add alternate sole-provider One copy to patient, one copy in EMR If at a Military Treatment Facility (MTF), may restrict to that MTF and listed providers

21 Pain Contract c td Review risk/benefits List precautions Driving safety Occupational safety (remember appropriate profiling for Active Duty) Security & safe-keeping of drugs NO use of alcohol or benzodiazepines while on opioids Consequences of noncompliance Maintain continuity - DON T kick patient out of clinic Increase visits / change approach aggressively manage pain without using opioids if needed PCMH team members can assist with this so that it doesn t take up provider visit time

22 Treatment Plan Informed Consent Side effects of opioids Sedation Dizziness nausea Constipation Hyperalgesia (increased pain) Physical dependence Delayed gastric emptying Hormonal dysfunction Erectile dysfunction Abuse Tolerance Respiratory depression

23 Treatment Plan Pharmacologic Non-opioids opioids Non-Pharmacologic Relaxation techniques Biofeedback CBT / IBT Journaling Support Groups Lifestyle Changes Exercise Weight loss CAM Acupuncture/BFA Spinal manipulation massage PM&R Heat/ice TENS Hydrotherapy Assistive devices Specialty Referral Physical Therapy Pain Management Other

24 Treatment Plan Leave room for functional goals Include recommended consultants PT / PM&R Ortho Pain med Rheum List all meds on plan Patient, PCM, & alternate all sign Give copy to patient (can send via Secure Message) Scan into EMR Review/revisit as needed

25 Your back still hurts?

26 Barrier: Drug-Seekers Pain contract / treatment agreement/ care plan Office policy with scripts Documentation Frequent visits, small quantities Use one pharmacy No early refills; pill counts utilize pharm D PDMP UDS Required consultation w/other specialties as indicated

27 Scripted Responses Your pain has been at a for months/years. Usually it s not possible to completely eliminate pain. Let s shift focus to getting your pain to a more tolerable level. How does that sound to you? I do not feel comfortable prescribing for this diagnosis, however we can try a prescription for instead which should also help.

28 Barriers: Insufficient Time Homework for patient: Pain diary Collect info prior to visit Phone or Secure Messaging Use standardized surveys Utilize pharm D to review PDMP Clinical assistant can do UDS Plan q2 week visits initially to reassess, reexamine then space out as appropriate

29 Barriers: Insufficient Time C td Screener can review pain contract & treatment plan with patient Utilize group visits (consider VTC) sleep class pain school Utilize Comprehensive Care Plan (CCP)Tab in AHLTA documents changes Requires tech training

30 Standardized Surveys Opioid Risk Opioid Risk Tool Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R ) Current Opioid Misuse Measure (COMM ) Function Oswestry Disability Questionnaire Pain eval Brief Pain Inventory

31 Opioid Risk Tool Low risk: 0-4 Opioid Risk Tool Score if Femal e Score if Male Mod risk: 4-7 High risk: 8 Family History of Substance Abuse Personal History of Substance Abuse Alcohol Illegal Drugs Prescription Drugs Alcohol Illegal Drugs Prescription Drugs Age (mark box if 16-45) 1 1 Webster 2005 History of Preadolescen t Sexual Abuse 3 0 Psychological Disease ADHD; OCD; Bipolar Disorder; 2 2

32 Patient Education Not limited to provider Starts with first visit Include family / caregivers Put goals in writing for patient & EMR Reinforce with office staff, IBHC, Pharm D Get creative w/barriers utilize videos, telecounseling Patient self-management Familydoctor.org: safe storage of opioids (trifold) Painmed.org This never ends!

33 Provider Education Opioid Risk Evaluation & Mitigation Strategy (REMS) soon to be mandatory Utilize PCMH resources: Pharm D, IBHC Grand Rounds Telemedicine consultation Pain ECHO program Free CME (AAFP) Pain Week This never ends!

34 Questions?

35 Resources VA/DoD Clinical Practice Guideline for the Management of Opioid Therapy (OT) for Chronic Pain (2010): includes pocket cards & guidelines, referral fact sheets, tapering fact sheets, side effect fact sheet: Opioid Risk Instruments (including Opioid Risk Tool (ORT) and SOAPP-R): State Monitoring Drug Programs:

36 Resources Continued REMS Physician Education Sample Patient Medication Management Agreement: Pain diary: _Notebook.pdf Patient education from painmed.org: nter/patienteducation/patient_education_main. aspx

37 References 1. Evans F, Whitham JA, David RM et al. An evaluation of Family Medicine residents attitudes before and after a PCMH innovation for patients with Chronic Pain. Fam Med Nov-Dec;43(10): Gomes et al. Opioid and Drug-Related Mortality in Patients with Non-Malignant Pain. Arch Intern Med. 2011; 171: Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med Mar-Apr;6(2): Hariharan J et al. Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. Journal of General Internal Medicine. 2007; 22: Passok SD, Weinreb HJ. Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids. Adv Ther. 2000; 17(2): NCQA 7. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med Nov-Dec; 6(6): Zacharoff KL. A Systematic Approach to the use of opioids in the treatment of chronic pain. February 19, Accessed February 21, 2014.

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA Department of Veterans Affairs Network Policy No.: 2014-01 VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA CHRONIC OPIOID USE FOR NON-MALIGNANT PAIN 1. PURPOSE: To

More information

Risk Reduction Strategies in Pain Management

Risk Reduction Strategies in Pain Management Risk Reduction Strategies in Pain Management Melissa J. Durham, PharmD, MACM, BCACP, DAAPM Assistant Professor of Clinical Pharmacy USC School of Pharmacy Clinical Pharmacist, The USC Pain Center Learning

More information

The Dark Art. Of Supervising & Managing Controlled Substances

The Dark Art. Of Supervising & Managing Controlled Substances The Dark Art Of Supervising & Managing Controlled Substances David A. Frenz, M.D. Vice President & Executive Medical Director North Memorial Health Care Robbinsdale, Minn. 27 October 2016 www.doctorfrenz.com

More information

Chronic Disease Management for Pain: It CAN be done in primary care!

Chronic Disease Management for Pain: It CAN be done in primary care! Chronic Disease Management for Pain: It CAN be done in primary care! Sondra Adkinson, PharmD, DAAPM, CPE Thomas B. Gregory, Pharm.D., BCPS, DASPE, CPE Chris Herndon, PharmD, BCPS, CPE Disclosures Adkinson:

More information

Opioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM

Opioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM Western Occupational Health Conference September 14, 2012 Opioid - Use & Misuse Scott Levy, MD MPH FACOEM Steven Feinberg, MD, MPH Disclosure Information Western Occupational Health Conference 2012 Steven

More information

No disclosures for any of the speakers!

No disclosures for any of the speakers! Opiate Use Disorders and Pain in the elderly: Integrating care with the pain specialist Gabriel Paulian M.D Christopher Ong, M.D Yuliet Sanchez, M.D Uma Suryadevara, M.D No disclosures for any of the speakers!

More information

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids? Learning objectives 1. Identify the contribution of psychosocial and spiritual factors to pain 2. Incorporate strategies for identifying and mitigating opioid misuse 3. Incorporate non-pharmaceutical modalities

More information

Chronic Pain Management in the Primary Care Setting

Chronic Pain Management in the Primary Care Setting Chronic Pain Management in the Primary Care Setting Keeping you and your patients safe. Joel Porter, MD October 1, 2015 Chronic Pain Management Chronic pain is a major public health problem Existing chronic

More information

Medication Management

Medication Management Marina Treglia, AGPCNP BC April 4, 2019 Medication Management Identify patient criteria for risk mitigation in a medication management program at a multidisciplinary pain clinic Discuss opioid discontinuation

More information

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships

More information

Nurse Practitioner Practice Guideline Treatment Agreements

Nurse Practitioner Practice Guideline Treatment Agreements Nurse Practitioner Practice Guideline Treatment Agreements In November 2012, the New Classes of Practitioners Regulations (NCPR) under Canada s Controlled Drug and Substances Act (CDSA) came into force,

More information

5 A s Opioid therapy monitoring tool

5 A s Opioid therapy monitoring tool 5 A s Opioid therapy monitoring tool Once initiating opioid therapy, it should be monitored regularly by assessing what has been called the 5As of Analgesia therapy. This monitoring tool, will assist you

More information

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient Approaches to Responsible Opioid Prescribing The Opioid Naïve Patient Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

Use of Opioids for Chronic Non Malignant Pain (CNMP)

Use of Opioids for Chronic Non Malignant Pain (CNMP) I. PURPOSE Use of Opioids for Chronic Non Malignant Pain (CNMP) We the Safe Opioid Prescribing and Review Committee (SOPARC) are inspired to support a shift in opioid prescribing that improves clinical

More information

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Noah Nesin, MD, FAAFP, Vice President of Medical Affairs, Penobscot Community Health Care Felicity Homsted, PharmD, DPLA, Chief

More information

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond David Anisman, MD Medical Director, Farmington Health Center (Primary Care) Associate Medical Director, Community

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

NBPDP Drug Utilization Review Process Update

NBPDP Drug Utilization Review Process Update Bulletin # 802 December 1, 2010 NBPDP Drug Utilization Review Process Update The New Brunswick Prescription Drug Program (NBPDP) employs a Drug Utilization Review (DUR) process which identifies, investigates

More information

Best Practices for Prescribing Controlled Substances

Best Practices for Prescribing Controlled Substances Best Practices for Prescribing Controlled Substances Dr. Merrill Norton Pharm.D., D.Ph, ICCDP-D Clinical Associate Professor University of Georgia College of Pharmacy mernort@uga.edu Georgia Composite

More information

ADDRESSING PRESCRIPTION PAIN MEDICINE ABUSE & MISUSE: A FRAMEWORK FORSAFE PRESCRIBING

ADDRESSING PRESCRIPTION PAIN MEDICINE ABUSE & MISUSE: A FRAMEWORK FORSAFE PRESCRIBING Kevin L. Zacharoff, MD, FACIP, FACPE, FAAP Clinical Anesthesiology & Pain Medicine Medical Director, PainEDU.org ADDRESSING PRESCRIPTION PAIN MEDICINE ABUSE & MISUSE: A FRAMEWORK FORSAFE PRESCRIBING PRESENTATION

More information

Opioids in the Management of Chronic Pain: An Overview

Opioids in the Management of Chronic Pain: An Overview Opioids in the Management of Chronic Pain: An Overview Appropriate treatment of chronic pain may include both pharmacologic and non-pharmacologic modalities. The Board realizes that controlled substances,

More information

Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R)

Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) The Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) is a tool for clinicians to help determine how much

More information

Controlled Substance and Wellness Agreement

Controlled Substance and Wellness Agreement Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Assessment and Management of Chronic Pain Guideline Summary

Assessment and Management of Chronic Pain Guideline Summary I CSI I NSTITUTE FOR CLINICAL S YSTEMS IMPROVEMENT Implementation Tool: Assessment and Management of Chronic Pain Guideline Summary Assessment Algorithm A = Annotation 1 Patient has pain 2 Critical first

More information

Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain

Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Management Centre; Centre for Addiction and Mental Health Toronto,

More information

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose 1 Learning Objectives Identify pain treatment related regulatory agencies Discuss the changing role of regulatory

More information

ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE

ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE You are a 58 year old man/woman and have a history of severe chronic low back pain for 20 years. You injured your back 20 years ago at work and have

More information

ScO.S. Academic Detailing for Safer Prescribing

ScO.S. Academic Detailing for Safer Prescribing ScO.S. Academic Detailing for Safer Prescribing Sarah Ball, PharmD Research Assistant Professor MUSC College of Medicine September 6, 2017 Megan Pruitt, PharmD SCORxE Clinical Pharmacy Consultant MUSC

More information

Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina

Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina Robert B. Hanlin, M.D., FAAFP Vice Chair, Medical Staff Affairs Greenville Health System Greenville, SC Disclosures

More information

Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation

Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation Learning Objectives Effective, Safe Analgesia An Approach to Appropriate Outpatient Chronic Pain Treatment By the end of this presentation, participants will be able to: Identify multiple factors that

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Applying Universal Precautions to Chronic Opioid Therapy 5P s Assessment

Applying Universal Precautions to Chronic Opioid Therapy 5P s Assessment Elements of Leverage Point #3: Applying Universal Precautions to Chronic Opioid Therapy 1. Diagnosis with reasonable differential 2. Psychological assessment including risk of addictive disorders Purpose

More information

Balance chronic pain management and responsible opioid prescribing. Michelle Bardack, M.D. Family & Community Medicine April 27, 2011

Balance chronic pain management and responsible opioid prescribing. Michelle Bardack, M.D. Family & Community Medicine April 27, 2011 Balance chronic pain management and responsible opioid prescribing Michelle Bardack, M.D. Family & Community Medicine Overview Frame the dilemma Federation of State Medical Boards Discussion and questions

More information

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Ajay D. Wasan, MD, MSc Professor of Anesthesiology and Psychiatry Vice Chair for Pain Medicine, Department of Anesthesiology University

More information

Disclosures 6/5/2017. Dr. Franklin has no disclosures Dr. Ngo has no disclosures

Disclosures 6/5/2017. Dr. Franklin has no disclosures Dr. Ngo has no disclosures Tu Ngo, PhD, MPH Julie Franklin, MD, MPH International Conference on Opioids Boston, MA June 11, 2017 1 Disclosures Dr. Franklin has no disclosures Dr. Ngo has no disclosures 2 Objectives Identify areas

More information

4/3/2018. The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers. Learning Objectives

4/3/2018. The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers. Learning Objectives The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers Melissa Durham Tania Gregorian Vlada Manzur Learning Objectives Describe current issues

More information

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse Advances in pharmacologic therapy have improved quality of life for patients living with pain, ADHD, and other conditions.

More information

Rule Governing the Prescribing of Opioids for Pain

Rule Governing the Prescribing of Opioids for Pain Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This

More information

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing

More information

FOR: JONATHAN WOODSON, M.D., ASSISTANT SECRETARY OF DEFENSE (HEALTH AFFAIRS)

FOR: JONATHAN WOODSON, M.D., ASSISTANT SECRETARY OF DEFENSE (HEALTH AFFAIRS) DEFENSE HEALTH BOARD FIVE SKYLINE PLACE, SUITE 810 5111 LEESBURG PIKE FALLS CHURCH, VA 22041-3206 FOR: JONATHAN WOODSON, M.D., ASSISTANT SECRETARY OF DEFENSE (HEALTH AFFAIRS) SUBJECT: Interim Report: Department

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Utah. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view

More information

Alcohol Misuse Clinical Pathway Outline

Alcohol Misuse Clinical Pathway Outline Alcohol Misuse Clinical Pathway Outline 1. Identification of Patients for Alcohol Misuse Pathway a. Criteria for inclusion into alcohol misuse clinical pathway: Patients meeting the following criteria

More information

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Vermont. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of

More information

Integrated Treatment of Co-morbid

Integrated Treatment of Co-morbid Opportunities and Challenges in Integrated Treatment of Co-morbid Chronic Pain and Substance Use Disorders Mark Ilgen, PhD Ann Arbor VA, HSR&D Center of Excellence; Serious Mental Illness Treatment and

More information

Opioid analgesic therapy in pain management: how we got here from there

Opioid analgesic therapy in pain management: how we got here from there National Organization of Alternative Programs March 17, 2016 Opioid analgesic therapy in pain management: how we got here from there Gary M. Reisfield, M.D. Divisions of Addiction Medicine and Forensic

More information

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid

More information

Best Practices and Foundation Forum. Fred Wells Brason II

Best Practices and Foundation Forum. Fred Wells Brason II Best Practices and Foundation Forum Fred Wells Brason II fbrason@projectlazarus.org Wilkes County, NC Manual labor dominates employment options in this county of 69,000. Wilkes 4 Marvelous M s Moonshine

More information

Drug Overdoses A Public Health Problem. Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013. Objectives

Drug Overdoses A Public Health Problem. Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013. Objectives Drug Overdoses A Public Health Problem Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013 Objectives O Provide an overview of the trends in opioid prescriptions and impact O Consider implications for the

More information

Ahsan U. Rashid, M.D., F.A.C.P.

Ahsan U. Rashid, M.D., F.A.C.P. Ahsan U. Rashid, M.D., F.A.C.P. OPIOID MAINTENANCE AND CONSENT Instructions: Review this document before signing. This document will help both the patient and caregivers in establishing a medical program

More information

Pain, Opioids and the EMR. Dr. Gordon Schacter April 12, 2018

Pain, Opioids and the EMR. Dr. Gordon Schacter April 12, 2018 Pain, Opioids and the EMR Dr. Gordon Schacter April 12, 2018 Faculty/Presenter Disclosure Faculty: Gordon Schacter Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria:

More information

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017 July 2017 Background The Six Building Blocks were developed as part of a research project on Team Based Opioid Management in rural clinics. The three year research study is a collaboration between 20 rural

More information

Prescription Monitoring Program (PMP)

Prescription Monitoring Program (PMP) 06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid

More information

ASPMN Conference Baltimore, Maryland

ASPMN Conference Baltimore, Maryland ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled

More information

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use Effective Date: May 19, 2008 Revised Date: August 18, 2015 Approved by: Thomas M Tocher, MD, MPH, Chief Clinical Officer Policy Number: MED Policy 313 Title: Pain Management Long Term Opioid Use POLICY

More information

Recommendations in Opioid Prescribing Guidelines for Chronic Pain

Recommendations in Opioid Prescribing Guidelines for Chronic Pain Recommendations in Opioid Prescribing Guidelines for Chronic Pain The use of opioids for treating chronic pain has been increasing. 1 In 2010, an estimated 20% of patients presenting to physician offices

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Care Team Training. Key Components of Collaborative Care. Collaborative Team Approach 4/21/2014 PCP. Core Program. New Roles. Psychiatric Consultant

Care Team Training. Key Components of Collaborative Care. Collaborative Team Approach 4/21/2014 PCP. Core Program. New Roles. Psychiatric Consultant Team Training Key Components of Collaborative Collaborative Team Approach Patient PCP Manager New Roles Core Program Psychiatric Consultant Behavioral Health Clinicians Additional Clinic Resources Substance,

More information

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018 Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018 Disclosures None Educational Objectives Understand CA state medical board guidelines for prescribing opioids for chronic pain Understand the

More information

The Royal College of. Chiropractors. Chiropractic Quality Standard. Chronic Pain

The Royal College of. Chiropractors. Chiropractic Quality Standard. Chronic Pain The Royal College of Chiropractors Chiropractic Quality Standard Chronic Pain About the Royal College of Chiropractor s Quality Standards Quality Standards are tools designed to help deliver the best possible

More information

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Presented by Scott Levy M.D. M.P.H. FACOEM Assistant Regional Medical Director, Occupational Health Services The Permanente Medical Group

More information

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Preamble This Standard establishes the standards of practice and ethical requirements of all physicians

More information

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G

More information

PATIENT SIGNATURE: DOB: Date:

PATIENT SIGNATURE: DOB: Date: CINCINNATI PAIN PHYSICIANS, LLC (CPP) ACKNOWLEDGEMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES By signing below, I acknowledge that I have received a copy of CPP s Notice of Privacy Practices. The Notice

More information

Evaluating Abuse, Misuse, Diversion, Overdose, Addiction, and Death in the Patient Population

Evaluating Abuse, Misuse, Diversion, Overdose, Addiction, and Death in the Patient Population Evaluating Abuse, Misuse, Diversion, Overdose, Addiction, and Death in the Patient Population ISCTM February 18, 2014 Beatrice Setnik, Ph.D. INC Research, Raleigh, NC Overview Prevalence of Rx drug misuse,

More information

MEDICATION MANAGEMENT AGREEMENT

MEDICATION MANAGEMENT AGREEMENT MEDICATION MANAGEMENT AGREEMENT The goal of this agreement is to ensure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. The

More information

As part of the Opioid Analgesic REMS, all opioid analgesic companies must provide the following:

As part of the Opioid Analgesic REMS, all opioid analgesic companies must provide the following: Introduction FDA s Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain (January 2018) Background In July 2012, FDA approved

More information

Nancy Elder, MD, MSPH Cincinnati, Ohio

Nancy Elder, MD, MSPH Cincinnati, Ohio Nancy Elder, MD, MSPH Cincinnati, Ohio My neck has hurt ever since my motorcycle crash in 2001. You got to help me, Doc! Great. Another drug seeking patient wanting narcotics. When I was working and had

More information

The Challenge of Treating Pain

The Challenge of Treating Pain FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and

More information

Collaborating to reduce preventable harm from medications. Dale C. Slavin, Ph.D. Associate Director of Programs, Safe Use Initiative FDA/CDER

Collaborating to reduce preventable harm from medications. Dale C. Slavin, Ph.D. Associate Director of Programs, Safe Use Initiative FDA/CDER Collaborating to reduce preventable harm from medications Dale C. Slavin, Ph.D. Associate Director of Programs, Safe Use Initiative FDA/CDER FDA Regulatory Risk Evaluation and Mitigation Strategy (REMS)

More information

Hedis Behavioral Health Measures

Hedis Behavioral Health Measures Hedis Behavioral Health Measures Generating better health outcomes and improving HEDIS scores is a positive outcome for everyone. Magellan Complete Care is offering support by providing the details of

More information

Using CURES to combat prescription drug abuse/misuse

Using CURES to combat prescription drug abuse/misuse Using CURES to combat prescription drug abuse/misuse Speakers Nathan Painter PharmD, CDE Email: npainter@ucsd.edu Rabia Atayee, PharmD, BCPS Email: ratayee@ucsd.edu UC San Diego Skaggs School of Pharmacy

More information

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM April 28, 2017 Disclosure Relationship with commercial interests: None Professional roles: Addictions

More information

The Difficult Patient: Risk Mitigation Strategies

The Difficult Patient: Risk Mitigation Strategies The Difficult Patient: Risk Mitigation Strategies C. Scott Anthony, D.O. Pain Management of Tulsa 1 Opioid Backlash National emergency Opioids not indicated for chronic pain Forces pushing for reduction

More information

Clinical Safety & Effectiveness Cohort # 11

Clinical Safety & Effectiveness Cohort # 11 Clinical Safety & Effectiveness Cohort # 11 Safety in Opiate Prescribing DATE Educating for Quality Improvement & Patient Safety 1 Financial Disclosure Jane E. O Rorke, M.D, has no relevant financial relationships

More information

Readopt with amendment Med 502, effective (Document #11090), to read as follows:

Readopt with amendment Med 502, effective (Document #11090), to read as follows: Adopted Rules 11-2-16 1 Readopt with amendment Med 502, effective 5-3-16 (Document #11090), to read as follows: PART Med 502 OPIOID PRESCRIBING Med 502.01 Applicability. This part shall apply to the prescribing

More information

Trainwreck: Addressing Complex Pharmacotherapy With the Inherited Pain Patient

Trainwreck: Addressing Complex Pharmacotherapy With the Inherited Pain Patient Trainwreck: Addressing Complex Pharmacotherapy With the Inherited Pain Patient Douglas Gourlay MD, MSc, FRCPC, FASAM Disclosures Nothing to disclose 2 1 Learning Objectives Assess the prescription drug

More information

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Proposed Revision to Med (i)

Proposed Revision to Med (i) Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and

More information

Monte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID

Monte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID Monte H. Moore, MD Idaho Physical Medicine and Rehabilitation Meridian, ID Chronic pain brief review Opiates important things to know Factors in determining whether to use an opiate What to watch for if

More information

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs Changing the Tide An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs Ken Hahlweg MD, CCFP, FCFP Assistant Professor Department of Family Medicine

More information

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Lucas Buffaloe, MD Associate Professor of Clinical Family and Community Medicine University of Missouri Health Care Goals for today

More information

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Opioid Pain Contracts: A Resident Driven Quality Improvement Project Opioid Pain Contracts: A Resident Driven Quality Improvement Project A Response to the Opioid Epidemic Dr. Phillip Knouse Dr. Victoria Montgomery Disclosure None Objectives Discuss the current Opioid Epidemic

More information

Medication Agreements Promoting awareness, dialogue and level-set expectations

Medication Agreements Promoting awareness, dialogue and level-set expectations Medication Agreements Promoting awareness, dialogue and level-set expectations A young man had his leg amputated following a work-related injury. His pain doctor, by all accounts, was trying to responsibly

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law

WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law Wayne L. Williams Douglas P. Wyckoff Dane D. Ostrander 2958 Limited Lane N.W. P O Box 316 Olympia, WA 98507 Telephone (360) 528-4800 Telefax (360) 943-2430

More information

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE INDICATION Naltrexone is a pure opiate antagonist licensed as an adjunctive prophylactic therapy in the maintenance

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar OPIOID PRESCRIBING RULES May 17, 2017 Webinar Outline Introduction and Universal Precautions Dr. Levine, Commissioner, Health Department 15 Minutes Acute Pain Dr. Patti Fisher, UVMMC 20 Minutes Chronic

More information

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014 MAT for Opioid Dependence Methadone maintenance treatment (MMT) Buprenorphine/naloxone (suboxone) Buprenorhine/naloxone (BupNX) Buprenorphine SL Parenteral naltrexone (P-ntx) Oral naltrexone (ntx) MAT

More information

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This

More information

Defense Health Board

Defense Health Board Defense Health Board Psychotropic Medication and Complementary and Alternative Medicine Interim Report Charles J. Fogelman, Ph.D. Psychological Health External Advisory Subcommittee Chair Michael D. Parkinson,

More information

Pain and Addiction. Edward Jouney, DO Department of Psychiatry

Pain and Addiction. Edward Jouney, DO Department of Psychiatry Pain and Addiction Edward Jouney, DO Department of Psychiatry Case 43 year-old female with a history chronic lower back pain presents to your clinic ongoing care. She has experienced pain difficulties

More information

Behavioral Medicine and Coaching Solutions for Chronic Pain Claims SIIA

Behavioral Medicine and Coaching Solutions for Chronic Pain Claims SIIA Behavioral Medicine and Coaching Solutions for Chronic Pain Claims SIIA Michael Coupland, RPsych, CRC IMCS Group Inc. Becky Curtis, Integrated Medical Case Solutions President and Founder Michael Coupland,

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Chronic Pain & Depression: A Roller Coaster Ride. Lori Higa, BSN, RN-BC

Chronic Pain & Depression: A Roller Coaster Ride. Lori Higa, BSN, RN-BC Chronic Pain & Depression: A Roller Coaster Ride Lori Higa, BSN, RN-BC Objectives By the end of this Webinar you will be able to: Help patient to be a good self-advocate Discuss treatment options with

More information